Mehdi Razavi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mehdi Razavi has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Allison Post
Texas Heart Institute
3 shared publicationsMathews John
Texas Heart Institute
3 shared publications- Aydin Babakhani
Department of Neurobiology, University of Texas Medical Branch at Galveston, TX, 77555
2 shared publications Brian Greet
School of Medicine, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030, USA
2 shared publicationsDavid Burkland
School of Medicine, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030, USA
2 shared publications- Hongming Lyu
School of Information Science and Technology and the State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai, China
2 shared publications
Latest Publications
- Open Access
- 18 May 2023
- Published by Springer Nature in Research Square
Injectable hydrogel electrodes as conduction highways to restore native pacing
There is an urgent clinical need for a preventative treatment regimen that addresses the underlying pathophysiology of ventricular arrhythmias, the leading cause of sudden cardiac death. The current report describes a new approach in cardiac rhythm management that leverages the native coronary anatomy for creation of flexible electrodes to directly and uniformly stimulate mid-myocardial tissues. Successful in vivo deployment of an injectable hydrogel electrode was achieved in a pig model via the rapid, in situ gelation of the two component hydrogel precursors to transform the vein into a flexible electrode with access far more refined than any current technologies allow. In addition to successful capture and pacing of the heart, analysis of surface ECG tracings and three-dimensional electroanatomic mapping revealed a QRS morphology comparable to native sinus rhythm, strongly suggesting the hydrogel electrode captures the deep septal bundle branches and Purkinje fibers. In an ablation model, electroanatomic mapping data demonstrated that the activation wavefront from the hydrogel reaches the mid-myocardium and endocardium much earlier than current single-point pacing modalities. Such uniform, controlled activation of broad swaths of tissue with wavefront propagation from the hydrogel electrode enables a unique opportunity to minimize the delayed myocardial conduction of heterogeneous tissue that underpins re-entry. Chronic studies using a pig model confirmed safety with absence of myocardial necrosis or retention of myocardial function. Collectively, these studies demonstrate the feasibility of a new pacing modality that most closely resembles native conduction with the potential to eliminate lethal re-entrant arrhythmias and provide painless defibrillation.
- 18 May 2023
- Published by Springer Nature in Research Square
Open AccessInjectable hydrogel electrodes as conduction highways to restore native pacing
There is an urgent clinical need for a preventative treatment regimen that addresses the underlying pathophysiology of ventricular arrhythmias, the leading cause of sudden cardiac death. The current report describes a new approach in cardiac rhythm management that leverages the native coronary anatomy for creation of flexible electrodes to directly and uniformly stimulate mid-myocardial tissues. Successful in vivo deployment of an injectable hydrogel electrode was achieved in a pig model via the rapid, in situ gelation of the two component hydrogel precursors to transform the vein into a flexible electrode with access far more refined than any current technologies allow. In addition to successful capture and pacing of the heart, analysis of surface ECG tracings and three-dimensional electroanatomic mapping revealed a QRS morphology comparable to native sinus rhythm, strongly suggesting the hydrogel electrode captures the deep septal bundle branches and Purkinje fibers. In an ablation model, electroanatomic mapping data demonstrated that the activation wavefront from the hydrogel reaches the mid-myocardium and endocardium much earlier than current single-point pacing modalities. Such uniform, controlled activation of broad swaths of tissue with wavefront propagation from the hydrogel electrode enables a unique opportunity to minimize the delayed myocardial conduction of heterogeneous tissue that underpins re-entry. Chronic studies using a pig model confirmed safety with absence of myocardial necrosis or retention of myocardial function. Collectively, these studies demonstrate the feasibility of a new pacing modality that most closely resembles native conduction with the potential to eliminate lethal re-entrant arrhythmias and provide painless defibrillation.
- Open Access
- 7 April 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1
Author Correction: Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 7 April 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1
Open AccessAuthor Correction: Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- Open Access
- 7 February 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-9
Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers
About 30% of patients with impaired cardiac function have ventricular dyssynchrony and seek cardiac resynchronization therapy (CRT). In this study, we demonstrate synchronized biventricular (BiV) pacing in a leadless fashion by implementing miniaturized and wirelessly powered pacemakers. With their flexible form factors, two pacemakers were implanted epicardially on the right and left ventricles of a porcine model and were inductively powered at 13.56 MHz and 40.68 MHz industrial, scientific, and medical (ISM) bands, respectively. The power consumption of these pacemakers is reduced to µW-level by a novel integrated circuit design, which considerably extends the maximum operating distance. Leadless BiV pacing is demonstrated for the first time in both open-chest and closed-chest porcine settings. The clinical outcomes associated with different interventricular delays are verified through electrophysiologic and hemodynamic responses. The closed-chest pacing only requires the external source power of 0.3 W and 0.8 W at 13.56 MHz and 40.68 MHz, respectively, which leads to specific absorption rates (SARs) 2–3 orders of magnitude lower than the safety regulation limit. This work serves as a basis for future wirelessly powered leadless pacemakers that address various cardiac resynchronization challenges.
- 7 February 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-9
Open AccessSynchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers
About 30% of patients with impaired cardiac function have ventricular dyssynchrony and seek cardiac resynchronization therapy (CRT). In this study, we demonstrate synchronized biventricular (BiV) pacing in a leadless fashion by implementing miniaturized and wirelessly powered pacemakers. With their flexible form factors, two pacemakers were implanted epicardially on the right and left ventricles of a porcine model and were inductively powered at 13.56 MHz and 40.68 MHz industrial, scientific, and medical (ISM) bands, respectively. The power consumption of these pacemakers is reduced to µW-level by a novel integrated circuit design, which considerably extends the maximum operating distance. Leadless BiV pacing is demonstrated for the first time in both open-chest and closed-chest porcine settings. The clinical outcomes associated with different interventricular delays are verified through electrophysiologic and hemodynamic responses. The closed-chest pacing only requires the external source power of 0.3 W and 0.8 W at 13.56 MHz and 40.68 MHz, respectively, which leads to specific absorption rates (SARs) 2–3 orders of magnitude lower than the safety regulation limit. This work serves as a basis for future wirelessly powered leadless pacemakers that address various cardiac resynchronization challenges.